Arkolith/Insider Trading/ZNTL/Form 4

Goel David E.

10% OwnerZentalis Pharmaceuticals, Inc. (ZNTL) · full profile →Form 4 · filed Dec 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.0M
Net Open-Market Flow
-$10.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2025Sell(S)7.5M$1.33$10.0M6.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-005288) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML